Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $8,099,995 |
| Sells | 11 | $41,257,732 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 28 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 25 Jan 2024 16:32 | EWTX | Edgewise Therapeutics Inc | THOMPSON PETER A. | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
| 29 Dec 2023 16:20 | ALPN | ALPINE IMMUNE SCIENCES Inc | THOMPSON PETER A. | Director | 28 Dec 2023 | Sale | 1,195,683 | 18.32 | 21,904,913 | I |
| 29 Dec 2023 16:20 | ALPN | ALPINE IMMUNE SCIENCES Inc | THOMPSON PETER A. | Director | 28 Dec 2023 | Sale | 139,166 | 18.32 | 2,549,521 | I |
| 29 Dec 2023 16:20 | ALPN | ALPINE IMMUNE SCIENCES Inc | THOMPSON PETER A. | Director | 28 Dec 2023 | Sale | 3,128 | 19.82 | 61,997 | I |
| 29 Dec 2023 16:20 | ALPN | ALPINE IMMUNE SCIENCES Inc | THOMPSON PETER A. | Director | 28 Dec 2023 | Sale | 26,872 | 19.82 | 532,603 | I |
| 29 Dec 2023 16:20 | ALPN | ALPINE IMMUNE SCIENCES Inc | THOMPSON PETER A. | Director | 27 Dec 2023 | Sale | 18,922 | 19.96 | 377,683 | I |
| 29 Dec 2023 16:20 | ALPN | ALPINE IMMUNE SCIENCES Inc | THOMPSON PETER A. | Director | 27 Dec 2023 | Sale | 162,576 | 19.96 | 3,245,017 | I |
| 31 Aug 2023 17:18 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 29 Aug 2023 | Purchase | 500,000 | 6.2 | 3,100,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)